Mass treatment with azithromycin for trachoma control: participation clusters in households.

<h4>Background</h4>Mass treatment to trachoma endemic communities is a critical part of the World Health Organization SAFE strategy. However, non-participation may not be at random, affecting coverage surveys and effectiveness if infection is differential.<h4>Methodology/principal...

Full description

Saved in:
Bibliographic Details
Main Authors: Elizabeth N Ssemanda, Beatriz Munoz, Emma M Harding-Esch, Tansy Edwards, Harran Mkocha, Robin L Bailey, Ansumana Sillah, Dianne Stare, David C W Mabey, Sheila K West, PRET Project Team
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-10-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0000838&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849744356499521536
author Elizabeth N Ssemanda
Beatriz Munoz
Emma M Harding-Esch
Tansy Edwards
Harran Mkocha
Robin L Bailey
Ansumana Sillah
Dianne Stare
David C W Mabey
Sheila K West
PRET Project Team
author_facet Elizabeth N Ssemanda
Beatriz Munoz
Emma M Harding-Esch
Tansy Edwards
Harran Mkocha
Robin L Bailey
Ansumana Sillah
Dianne Stare
David C W Mabey
Sheila K West
PRET Project Team
author_sort Elizabeth N Ssemanda
collection DOAJ
description <h4>Background</h4>Mass treatment to trachoma endemic communities is a critical part of the World Health Organization SAFE strategy. However, non-participation may not be at random, affecting coverage surveys and effectiveness if infection is differential.<h4>Methodology/principal findings</h4>As part of the Partnership for Rapid Elimination of Trachoma (PRET), 32 communities in Tanzania, and 48 in The Gambia had a detailed census taken followed by mass treatment with azithromycin. The target coverage in each community was >80% of children ages <10 years. Community treatment assistants observed treatment and recorded compliance, thus coverage at the community, household, and individual level could be determined. Within each community, we determined the actual proportions of households where all, some, or none of the children were treated. Assuming the coverage in children <10 years of the community was as observed and non-participation was at random, we did 500 simulations to derive expected proportions of households where all, some, or none of the children were treated. Clustering of household treatment was detected comparing greater-than-expected proportions of households where none or all of children were treated, and the intraclass correlation (ICC) was calculated. Tanzanian and Gambian mass treatment coverages for children <10 years of age ranged from 82-100% and 62-99%, respectively. Clustering of households where all children were treated or no children were treated was greater than expected. Compared to model simulations, all Tanzanian communities and 44 of 48 (91.7%) Gambian communities had significantly higher proportions of households where all children were treated. Furthermore, 30 of 32 (93.8%) Tanzanian communities and 34 of 48 (70.8%) Gambian communities had a significantly elevated proportion of households compared to the expected proportion where no children were treated. The ICC for Tanzania was 0.77 (95% CI 0.74-0.81) and for The Gambia was 0.55 (95% CI 0.51-0.59).<h4>Conclusions/significance</h4>In programs aiming for high coverage, complete compliance or non-compliance with mass treatment clusters within households. Non-compliance cannot be assumed to be at random.
format Article
id doaj-art-fe4b02fa4f8243d9b95d27742b2c3566
institution DOAJ
issn 1935-2727
1935-2735
language English
publishDate 2010-10-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-fe4b02fa4f8243d9b95d27742b2c35662025-08-20T03:19:59ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352010-10-01410e83810.1371/journal.pntd.0000838Mass treatment with azithromycin for trachoma control: participation clusters in households.Elizabeth N SsemandaBeatriz MunozEmma M Harding-EschTansy EdwardsHarran MkochaRobin L BaileyAnsumana SillahDianne StareDavid C W MabeySheila K WestPRET Project Team<h4>Background</h4>Mass treatment to trachoma endemic communities is a critical part of the World Health Organization SAFE strategy. However, non-participation may not be at random, affecting coverage surveys and effectiveness if infection is differential.<h4>Methodology/principal findings</h4>As part of the Partnership for Rapid Elimination of Trachoma (PRET), 32 communities in Tanzania, and 48 in The Gambia had a detailed census taken followed by mass treatment with azithromycin. The target coverage in each community was >80% of children ages <10 years. Community treatment assistants observed treatment and recorded compliance, thus coverage at the community, household, and individual level could be determined. Within each community, we determined the actual proportions of households where all, some, or none of the children were treated. Assuming the coverage in children <10 years of the community was as observed and non-participation was at random, we did 500 simulations to derive expected proportions of households where all, some, or none of the children were treated. Clustering of household treatment was detected comparing greater-than-expected proportions of households where none or all of children were treated, and the intraclass correlation (ICC) was calculated. Tanzanian and Gambian mass treatment coverages for children <10 years of age ranged from 82-100% and 62-99%, respectively. Clustering of households where all children were treated or no children were treated was greater than expected. Compared to model simulations, all Tanzanian communities and 44 of 48 (91.7%) Gambian communities had significantly higher proportions of households where all children were treated. Furthermore, 30 of 32 (93.8%) Tanzanian communities and 34 of 48 (70.8%) Gambian communities had a significantly elevated proportion of households compared to the expected proportion where no children were treated. The ICC for Tanzania was 0.77 (95% CI 0.74-0.81) and for The Gambia was 0.55 (95% CI 0.51-0.59).<h4>Conclusions/significance</h4>In programs aiming for high coverage, complete compliance or non-compliance with mass treatment clusters within households. Non-compliance cannot be assumed to be at random.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0000838&type=printable
spellingShingle Elizabeth N Ssemanda
Beatriz Munoz
Emma M Harding-Esch
Tansy Edwards
Harran Mkocha
Robin L Bailey
Ansumana Sillah
Dianne Stare
David C W Mabey
Sheila K West
PRET Project Team
Mass treatment with azithromycin for trachoma control: participation clusters in households.
PLoS Neglected Tropical Diseases
title Mass treatment with azithromycin for trachoma control: participation clusters in households.
title_full Mass treatment with azithromycin for trachoma control: participation clusters in households.
title_fullStr Mass treatment with azithromycin for trachoma control: participation clusters in households.
title_full_unstemmed Mass treatment with azithromycin for trachoma control: participation clusters in households.
title_short Mass treatment with azithromycin for trachoma control: participation clusters in households.
title_sort mass treatment with azithromycin for trachoma control participation clusters in households
url https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0000838&type=printable
work_keys_str_mv AT elizabethnssemanda masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT beatrizmunoz masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT emmamhardingesch masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT tansyedwards masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT harranmkocha masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT robinlbailey masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT ansumanasillah masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT diannestare masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT davidcwmabey masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT sheilakwest masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds
AT pretprojectteam masstreatmentwithazithromycinfortrachomacontrolparticipationclustersinhouseholds